Shares of Hims & Hers Health ( HIMS -5.48%) and LifeMD ( LFMD -14.33%) are surging on Tuesday. The companie' stocks had ...

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer, lower cost version of its popular ...

Telehealth company LifeMD bought assets from Optimal Human Health MD to accelerate its push into the women’s health market. | ...

Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers , Ro and LifeMD to sell Wegovy, as it looks to ...

Pharma giant Novo Nordisk is partnering with telehealth companies to expand access to its blockbuster weight loss drug Wegovy ...

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announced plans to offer broad, affordable, and streamlined access to Wegovy® (semaglutide) through NovoCare® Pharmacy ...

LifeMD ® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment acros ...

LifeMD shares surged 22% after announcing plans to offer access to semaglutide, which is marketed as Wegovy to treat obesity, through NovoCare Pharmacy. Shares were trading around $7.49. The stock is ...

Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. The companie' stocks had jumped 24% and 34%, respectively, as of 3:15 p.m. ET as the S&P 500 and the ...

What To Know: LifeMD said it will offer access to Wegovy through Novocare Pharmacy, allowing the company to provide the weight-loss drug at a lower self-pay price of $499 per month. The company said ...

Novo Nordisk, the maker of Wegovy, announced exclusively on " Good Morning America " Tuesday that the medication will soon be available for purchase through the telehealth companies Ro, Hims and ...

Hims & Hers Health, LifeMD, Ro, and other platforms like them will now be able to sell Novo Nordisk's Wegovy, which is used for weight loss. The blockbuster GLP-1 should entice customers.